Searched for
DCGI
Wockhardt expands novel antibiotic Miqnaf's access; Q2 revenue rises 24%Wockhardt has expanded its marketing access for Miqnaf in India following the removal of a supply condition. The company's biotechnology se...- Court discharges former drug regulator S Eswara Reddy, three others in corruption caseThe court found that the call recordings relied on by the prosecution did not attribute criminality to Reddy. None of the accused, it noted...
- States urged to enforce ban on reuse of single-use medical devicesThe Directorate General of Health Services has issued a directive to prohibit the reuse of single-use medical devices. Violations by some p...
- Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruptionDr Reddy’s Laboratories has expanded its generic semaglutide portfolio with Obeda Pro and Obeda Plus after supplies of its original Obeda i...
- From nasal delivery to sterile injectables: Biodeal Pharmaceuticals’ expansion plansBiodeal Pharmaceuticals is set to broaden its horizons with a state-of-the-art sterile injectables plant in Himachal Pradesh. This venture ...
- Dr Reddy's gets DCGI nod for Zytorvi in advanced esophageal cancerDr Reddy's Laboratories has received approval for Zytorvi, an immunotherapy targeting advanced esophageal squamous cell carcinoma. This new...
- National Formulary of India lists drugs not approved by CDSCO, DCGI seeks explanation from IPCThe National Formulary of India released its latest edition amidst concerns regarding unapproved drugs included in it. The Drug Controller ...
- Lupin launches fixed-dose triple combination inhaler for COPD in IndiaLupin Ltd has launched Formoflo-G MDI, a new inhaler for chronic obstructive pulmonary disease management in India. This fixed-dose inhaler...
- QDENGA dengue vaccine to hit India market in 2027; Dr Reddy’s to sell itIndia's first approved dengue vaccine, QDENGA, will launch in the private market by mid-2027. Dr Reddy's Laboratories will distribute and p...
- Dr. Reddy's launches nivolumab biosimilar in IndiaDr Reddy's Laboratories has taken a significant step in cancer care with the introduction of NIVORZ, a biosimilar of nivolumab. Designed to...
- Zydus’ Saroglitazar meets primary goal in global Phase II(b) MASH trialZydus Lifesciences said its drug Saroglitazar Magnesium met the primary goal of a global Phase II(b) trial for MASH, a serious liver diseas...
- DCGI asks states to keep vigil on sale of falsified versions of 2 drugs following WHO alertsThe Drugs Controller General of India (DCGI) has issued an advisory to keep a strict watch on the sale and distribution of falsified versio...
- DCGI issues advisory as US-based Abbott recalls batches of Digene gelAbbott India Limited, through a letter dated August 18, intimated to DCGI regarding voluntary product recall of all batches of Digene Gel o...
- DCGI says medicines should be sold only under direct supervision of pharmacists in retail medical stores"Ensure that pharmacists are physically present in the retail pharmacies/medical stores, and that medicines are sold/dispensed under their ...
- DCGI chief VG Somani gets three months extensionThe extension period will come to effect from November 11. This is the second extension that Somani got. His term was set to end on August ...
- Dr Reddy's gets DCGI nod for single-shot Sputnik Light vaccineThe standalone Sputnik Light vaccine is the latest jab to be approved by the DCGI as part of India's national inoculation effort against CO...
- AstraZeneca's Dapagliflozin tablets get DCGI nod for patients with chronic kidney diseaseThe company has "received Import and Market Permission in Form CT-20 (Subsequent New Drug Approval) from the DCGI for Dapagliflozin tablets...
- Glenmark Pharma shares jump nearly 9% on DCGI nod for clinical trials of Covid-19 tabletsThe company said it is the first firm in India to receive such an approval from the DCGI.
- DCGI to fast-track approval for Covid-19 drug, vaccineThe DCGI has offered seven measures for speeding up the process, from giving fast-track approval for repurposed drug to waiving animal stud...
- Drug Regulator office has gone defunct as a quasi regulatory body takes charge of crucial approvalsDrug companies say that due to this committee, the DCGI has become non accountable to issues of drug approvals.
Load More
